Wilhelm J. Schwaeble

Wilhelm J. Schwaeble

Auto-generated profile, based on publicly available information

Wilhelm J. Schwaeble

Department of Infection, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
GAGéza Ambrus
Géza Ambrus
PGPéter Gál
Péter Gál
MKMayumi Kojima
Mayumi Kojima
KSKatalin Szilagyi
Katalin Szilagyi
JBJúlia Balczer
Júlia Balczer
PZPéter Závodszky
Péter Závodszky

18 April 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
WSWilhelm J. Schwaeble
Wilhelm J. Schwaeble
NLNicholas J. Lynch
Nicholas J. Lynch
JCJames Edward Clark
James Edward Clark
MMMichael Marber
Michael Marber
NSNilesh J. Samani
Nilesh J. Samani
Cordula StoverCordula Stover
Cordula Stover
Complement research experienced a renaissance with the discovery of a third activation route, the lectin pathway. We developed a unique model of total lectin pathway deficiency, a mouse strain lacking mannan-binding lectin-associated serine protease-2 (MASP-2), and analyzed the role of MASP-2 in two models of postischemic reperfusion injury (IRI). In a model of transient myocardial IRI, MASP-2–deficient mice had significantly smaller infarct volumes than their wild-type littermates. Mice deficient in the downstream complement component C4 were not protected, suggesting the existence of a previously undescribed lectin pathway-dependent C4-bypass. Lectin pathway-mediated activation of C3 in the absence of C4 was demonstrated in vitro and shown to require MASP-2, C2, and MASP-1/3. MASP-2 deficiency also protects mice from gastrointestinal IRI, as do mAb-based inhibitors of MASP-2. The therapeutic effects of MASP-2 inhibition in this experimental model suggest the utility of anti–MASP-2 antibody therapy in reperfusion injury and other lectin pathway-mediated disorders.

5 July 2012 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
YAYoussif M. Ali
Youssif M. Ali
NLNicholas J. Lynch
Nicholas J. Lynch
KHKashif S. Haleem
Kashif S. Haleem
TFTeizo Fujita
Teizo Fujita
YEYuichi Endo
Yuichi Endo
WSWilhelm J. Schwaeble
Wilhelm J. Schwaeble
The complement system plays a key role in host defense against pneumococcal infection. Three different pathways, the classical, alternative and lectin pathways, mediate complement activation. While there is limited information available on the roles of the classical and the alternative activation pathways of complement in fighting streptococcal infection, little is known about the role of the lectin pathway, mainly due to the lack of appropriate experimental models of lectin pathway deficiency. We have recently established a mouse strain deficient of the lectin pathway effector enzyme mannan-binding lectin associated serine protease-2 (MASP-2) and shown that this mouse strain is unable to form the lectin pathway specific C3 and C5 convertases. Here we report that MASP-2 deficient mice (which can still activate complement via the classical pathway and the alternative pathway) are highly susceptible to pneumococcal infection and fail to opsonize Streptococcus pneumoniae in the none-immune host. This defect in complement opsonisation severely compromises pathogen clearance in the lectin pathway deficient host. Using sera from mice and humans with defined complement deficiencies, we demonstrate that mouse ficolin A, human L-ficolin, and collectin 11 in both species, but not mannan-binding lectin (MBL), are the pattern recognition molecules that drive lectin pathway activation on the surface of S. pneumoniae. We further show that pneumococcal opsonisation via the lectin pathway can proceed in the absence of C4. This study corroborates the essential function of MASP-2 in the lectin pathway and highlights the importance of MBL-independent lectin pathway activation in the host defense against pneumococci. Streptococcus pneumoniae is a major human pathogen that causes pneumonia, septicemia and meningitis. The host defense against pneumococci is largely dependent on complement, a system of blood proteins which, when activated, attach to bacteria, targeting them for clearance by phagocytes. There are three routes of complement activation: The classical, lectin and alternative pathways. Limited information is available on the roles of the classical and alternative pathways in fighting pneumococci; the role of the lectin pathway has escaped the attention of previous research. This work demonstrates that the lectin pathway is critical in fighting pneumococcal infection. Of the five different lectin pathway recognition molecules in human serum, only L-ficolin and collectin 11 activate complement on pneumococci. Human mannose-binding lectin (MBL), the best-known lectin pathway pattern recognition molecule, has no role whatsoever in fighting pneumococci. Similarly, in mouse serum, only ficolin A and collectin 11 drive complement activation on S. pneumoniae. Hence, MBL deficient mice are not compromised in pneumococcal infection, while ficolin A deficient mice and mice deficient of the key lectin pathway enzyme MBL-associated serine protease-2 (MASP-2) are exquisitely susceptible to infection. This work explains why MBL deficiency, the most frequent hereditary immune deficiency, does not predispose to pneumococcal disease.

15 March 1999 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
Cordula StoverCordula Stover
Cordula Stover
STSteffen Thiel
Steffen Thiel
MTMarcus Thelen
Marcus Thelen
NLNicholas J. Lynch
Nicholas J. Lynch
TVThomas Vorup-Jensen
Thomas Vorup-Jensen
WSWilhelm J. Schwaeble
Wilhelm J. Schwaeble
Mannan-binding lectin (MBL) forms a multimolecular complex with at least two MBL-associated serine proteases, MASP-1 and MASP-2. This complex initiates the MBL pathway of complement activation by binding to carbohydrate structures present on bacteria, yeast, and viruses. MASP-1 and MASP-2 are composed of modular structural motifs similar to those of the C1q-associated serine proteases C1r and C1s. Another protein of 19 kDa with the same N-terminal sequence as the 76-kDa MASP-2 protein is consistently detected as part of the MBL/MASP complex. In this study, we present the primary structure of this novel MBL-associated plasma protein of 19 kDa, MAp19, and demonstrate that MAp19 and MASP-2 are encoded by two different mRNA species generated by alternative splicing/polyadenylation from one structural gene.

18 April 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CFConrad A. Farrar
Conrad A. Farrar
DTDavid Tran
David Tran
KLKe Li
Ke Li
WWWeiju Wu
Weiju Wu
QPQi Peng
Qi Peng
SSsteven Sacks
steven Sacks
Physiochemical stress induces tissue injury as a result of the detection of abnormal molecular patterns by sensory molecules of the innate immune system. Here, we have described how the recently discovered C-type lectin collectin-11 (CL-11, also known as CL-K1 and encoded by COLEC11) recognizes an abnormal pattern of L-fucose on postischemic renal tubule cells and activates a destructive inflammatory response. We found that intrarenal expression of CL-11 rapidly increases in the postischemic period and colocalizes with complement deposited along the basolateral surface of the proximal renal tubule in association with L-fucose, the potential binding ligand for CL-11. Mice with either generalized or kidney-specific deficiency of CL-11 were strongly protected against loss of renal function and tubule injury due to reduced complement deposition. Ex vivo renal tubule cells showed a marked capacity for CL-11 binding that was induced by cell stress under hypoxic or hypothermic conditions and prevented by specific removal of L-fucose. Further analysis revealed that cell-bound CL-11 required the lectin complement pathway–associated protease MASP-2 to trigger complement deposition. Given these results, we conclude that lectin complement pathway activation triggered by ligand–CL-11 interaction in postischemic tissue is a potent source of acute kidney injury and is amenable to sugar-specific blockade.

1 November 2012 in Immunobiology
Verified
Journal Article
Closed access
WGWilliam B. Gorsuch
William B. Gorsuch
ECElvina Chrysanthou
Elvina Chrysanthou
WSWilhelm J. Schwaeble
Wilhelm J. Schwaeble
GSGregory L. Stahl
Gregory L. Stahl